SCHEMBL6489619

SCHEMBL6489619

Cc1nc(-c2cc(C)c3nc(C)n(Cc4ccc(Cl)cc4Cl)c3c2)oc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C2B O00750 4/20 0.41
PPARG P37231 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
PMP22 Q01453 1/20 0.39
HIF1A Q16665 1/20 0.39
LMNA P02545 4/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
DCTPP1 Q9H773 1/20 0.37
NPC1 O15118 1/20 0.37
PIK3CB P42338 2/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CCR2 P41597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489123 0.90 LMNA (0.42) PIK3C2BPPARGTSHRCYP1A2CYP3A4
SCHEMBL6498830 0.90 PIK3C2B (0.41) PIK3C2BPPARGNPSR1CYP3A4CYP2C9
SCHEMBL6497985 0.85 PPARG (0.36) PIK3C2BPPARGALDH1A1KDM4ESMN1; SMN2
SCHEMBL6499907 0.82 PPARG (0.39) PIK3C2BPPARGNPSR1TSHRCYP1A2
SCHEMBL6489265 0.82 TARBP2 (0.42) PIK3C2BPPARGNPSR1TSHRCYP3A4
SCHEMBL6172911 0.81 PPARG (0.48) PIK3C2BPPARGNPSR1TSHRCYP1A2
SCHEMBL6490645 0.80 PTGDR (0.44) PIK3C2BPPARGNPSR1TSHRCYP1A2
SCHEMBL7172666 0.80 PIK3C2B (0.42) PIK3C2BPPARGNPSR1TSHRCYP1A2
SCHEMBL6489601 0.79 NPSR1 (0.41) PIK3C2BPPARGNPSR1TSHRCYP1A2
SCHEMBL6494714 0.79 KDM4C (0.44) PPARGNPSR1TSHRCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD PIK3C2B 2433/4885PPARG 233/4885NPSR1 4348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.